[1]
“Development and Optimization of Apixaban Loaded Solid Lipid Nanoparticles by Central Composite Design, in vitro and ex vivo Characterization”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 5, pp. 581–588, Sep. 2022, doi: 10.25004/IJPSDR.2022.140511.